Myriad Genetics | MYGN - Assets


Myriad Genetics reported $638.9M in Assets for its fiscal quarter ending in June of 2026.





Assets Change Date
Agilent USD 13.97B 902M Jun/2026
Becton, Dickinson and Co. USD 50.79B 60M Sep/2026
Bio-Rad Laboratories USD 10.78B 531.1M Sep/2026
Bruker USD 5.83B 224.6M Sep/2026
Danaher USD 93.28B 914M Sep/2026
Illumina USD 6.81B 162M Sep/2026
J&J USD 197.42B 3.64B Sep/2026
Mettler Toledo International USD 3.7B 24.53M Sep/2026
Myriad Genetics USD 638.9M 34.8M Jun/2026
OraSure Technologies USD 360.55M 18.62M Jun/2026
Pacific Biosciences Of California USD 721.1M 30.75M Sep/2026
Quest Diagnostics USD 17.22B 282M Sep/2026
Quidel USD 5.78B 66M Sep/2026
Repligen USD 2.93B 23.77M Sep/2026
Revvity USD 11.49B 555.49M Sep/2026
Standard Biotools USD 635.33M 8.11M Sep/2026
Thermo Fisher Scientific USD 114.23B 1.06B Sep/2026
Veracyte USD 1.57B 86.89M Sep/2026
Waters USD 24.12B 636M Sep/2026